Development of Chimeric Antigen Receptor-Modified NK Cells for the Immunotherapy of Adult T-Cell Leukemia/Lymphoma.

Eur J Haematol · 2026 · PMC13326765 · PMID 42070769

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In a xenograft mouse model, administration of irradiated CAR‐NK cells partially suppressed tumor burden as evidenced by reduced serum hsIL‐2R levels, although survival benefit did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.